Abacavir sulfate is a potent nucleoside reverse transcriptase inhibitor agent frequently administered in the management of human immunodeficiency virus (HIV) infection. It exerts its mechanism of action by competitively inhibiting the activity of the viral reverse transcriptase enzyme, thereby suppressing the conversion of HIV RNA to DNA. This bloc